Table 4.
Cost-effectiveness analysis.
| Strategy | Total infectious individuals (TI) | Total averted infectious individuals (TA) | Infection averted ratio (IAR) | Total cost (TC) | Incremental cost-effectiveness ratio (ICER) |
|---|---|---|---|---|---|
| Without control | 8843953 | – | – | – | - |
| Strategy A | 665124 | 8178829 | 92.4793% | 21938339 | 2.6823 |
| Strategy B | 1238052 | 7605901 | 86.0011% | 18524706 | 2.4356 |
| Strategy C | 8808889 | 35064 | 0.39647% | 140006768 | 3992.9 |
| Strategy D | 363361 | 8480592 | 95.8914% | 18559834 | 2.1885 |
| Strategy E | 664874 | 8179079 | 92.4822% | 52369219 | 6.4028 |
| Strategy F | 1236329 | 7607624 | 86.0206% | 71964375 | 9.4595 |
| Strategy G | 363292 | 8480661 | 95.8922% | 52256296 | 6.1618 |